The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review.

IF 3.3 4区医学 Q1 ECONOMICS

Applied Health Economics and Health Policy Pub Date : 2025-10-07 DOI:10.1007/s40258-025-01007-1

Austin J Triana, Mason N Alford-Holloway

{"title":"The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review.","authors":"Austin J Triana, Mason N Alford-Holloway","doi":"10.1007/s40258-025-01007-1","DOIUrl":null,"url":null,"abstract":"Background: Health care spending continues to rise, and recent policies have made prices more visible.Purpose: To assess how cost effectiveness analyses obtain price information for common cancer screenings and account for price variation.Methods: A systematic search of PUBMED was conducted, extracting studies from 2021 to 2024 in English and evaluating health care services in the USA. Cost-effectiveness analyses were included for four common cancer screenings: prostate cancer, breast cancer, colon cancer, and lung cancer. A single investigator extracted data and assessed quality, reviewed by a second investigator.Results: A total of 16 articles met inclusion criteria. Nearly all (94%) cited the Medicare Fee Schedule as the data source for pricing information. About half (44%) of analyses included a degree of price variation. Only three articles (19%) performed a cost-effectiveness analysis with a wide degree of price variation that accurately reflected the true degree of price variation observed in empirical data.Limitations: The sample size of included studies was modest, and generalizability is limited beyond these four common cancer screenings.Conclusions: Cost-effectiveness analyses in the USA need to reflect the wide price variation that exists in health care, and publicly available price transparency data should guide future work.","PeriodicalId":8065,"journal":{"name":"Applied Health Economics and Health Policy","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Health Economics and Health Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40258-025-01007-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Health care spending continues to rise, and recent policies have made prices more visible.

Purpose: To assess how cost effectiveness analyses obtain price information for common cancer screenings and account for price variation.

Methods: A systematic search of PUBMED was conducted, extracting studies from 2021 to 2024 in English and evaluating health care services in the USA. Cost-effectiveness analyses were included for four common cancer screenings: prostate cancer, breast cancer, colon cancer, and lung cancer. A single investigator extracted data and assessed quality, reviewed by a second investigator.

Results: A total of 16 articles met inclusion criteria. Nearly all (94%) cited the Medicare Fee Schedule as the data source for pricing information. About half (44%) of analyses included a degree of price variation. Only three articles (19%) performed a cost-effectiveness analysis with a wide degree of price variation that accurately reflected the true degree of price variation observed in empirical data.

Limitations: The sample size of included studies was modest, and generalizability is limited beyond these four common cancer screenings.

Conclusions: Cost-effectiveness analyses in the USA need to reflect the wide price variation that exists in health care, and publicly available price transparency data should guide future work.

查看原文本刊更多论文

价格变化在癌症筛查经济分析中的作用：快速回顾。

背景：卫生保健支出持续上升，最近的政策使价格更加明显。目的：评估成本效益分析如何获得普通癌症筛查的价格信息并解释价格变化。方法：系统检索PUBMED，提取2021 - 2024年的英文研究，对美国的卫生保健服务进行评价。成本效益分析包括四种常见的癌症筛查：前列腺癌、乳腺癌、结肠癌和肺癌。由一名研究者提取数据并评估质量，由另一名研究者审查。结果：共有16篇文章符合纳入标准。几乎所有（94%）的人都将医疗保险费用表作为定价信息的数据源。大约一半（44%）的分析包括一定程度的价格变化。只有三篇文章（19%）进行了成本效益分析，其中价格变化程度很大，准确反映了经验数据中观察到的价格变化的真实程度。局限性：纳入研究的样本量不大，除这四种常见的癌症筛查外，推广能力有限。结论：美国的成本效益分析需要反映医疗保健中存在的广泛价格差异，公开的价格透明度数据应指导未来的工作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Applied Health Economics and Health Policy Economics, Econometrics and Finance-Economics and Econometrics

CiteScore

6.10

自引率

2.80%

发文量

期刊介绍： Applied Health Economics and Health Policy provides timely publication of cutting-edge research and expert opinion from this increasingly important field, making it a vital resource for payers, providers and researchers alike. The journal includes high quality economic research and reviews of all aspects of healthcare from various perspectives and countries, designed to communicate the latest applied information in health economics and health policy. While emphasis is placed on information with practical applications, a strong basis of underlying scientific rigor is maintained.